CN112168181B - Brain tissue blood oxygen saturation detection device and preparation method thereof - Google Patents
Brain tissue blood oxygen saturation detection device and preparation method thereof Download PDFInfo
- Publication number
- CN112168181B CN112168181B CN202011114382.2A CN202011114382A CN112168181B CN 112168181 B CN112168181 B CN 112168181B CN 202011114382 A CN202011114382 A CN 202011114382A CN 112168181 B CN112168181 B CN 112168181B
- Authority
- CN
- China
- Prior art keywords
- optical fibers
- brain tissue
- oxygen saturation
- optical fiber
- blood oxygen
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 210000005013 brain tissue Anatomy 0.000 title claims abstract description 58
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 title claims abstract description 54
- 239000001301 oxygen Substances 0.000 title claims abstract description 54
- 229910052760 oxygen Inorganic materials 0.000 title claims abstract description 54
- 238000001514 detection method Methods 0.000 title claims abstract description 35
- 239000008280 blood Substances 0.000 title claims abstract description 27
- 210000004369 blood Anatomy 0.000 title claims abstract description 27
- 238000002360 preparation method Methods 0.000 title claims abstract description 6
- 239000013307 optical fiber Substances 0.000 claims abstract description 119
- 238000000227 grinding Methods 0.000 claims abstract description 8
- 238000005520 cutting process Methods 0.000 claims abstract description 3
- 239000000835 fiber Substances 0.000 claims description 31
- 239000002184 metal Substances 0.000 claims description 11
- 229910052751 metal Inorganic materials 0.000 claims description 11
- 239000010931 gold Substances 0.000 claims description 7
- 229910052737 gold Inorganic materials 0.000 claims description 7
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 6
- 238000000576 coating method Methods 0.000 claims description 5
- 239000000853 adhesive Substances 0.000 claims description 4
- 230000001070 adhesive effect Effects 0.000 claims description 4
- 238000013461 design Methods 0.000 claims description 4
- 239000011248 coating agent Substances 0.000 claims description 3
- 238000012986 modification Methods 0.000 claims description 3
- 230000004048 modification Effects 0.000 claims description 3
- 238000012545 processing Methods 0.000 claims description 3
- 238000007747 plating Methods 0.000 claims description 2
- 238000012544 monitoring process Methods 0.000 description 14
- 238000000034 method Methods 0.000 description 12
- 230000003287 optical effect Effects 0.000 description 12
- 210000003625 skull Anatomy 0.000 description 9
- 239000000126 substance Substances 0.000 description 9
- 238000010521 absorption reaction Methods 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000005259 measurement Methods 0.000 description 7
- KRHYYFGTRYWZRS-UHFFFAOYSA-N Fluorane Chemical compound F KRHYYFGTRYWZRS-UHFFFAOYSA-N 0.000 description 6
- 230000005540 biological transmission Effects 0.000 description 6
- 210000004556 brain Anatomy 0.000 description 6
- 210000004761 scalp Anatomy 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 5
- 102000001554 Hemoglobins Human genes 0.000 description 5
- 108010064719 Oxyhemoglobins Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 150000002739 metals Chemical class 0.000 description 5
- 230000002490 cerebral effect Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 2
- 238000004497 NIR spectroscopy Methods 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 230000007797 corrosion Effects 0.000 description 2
- 238000005260 corrosion Methods 0.000 description 2
- 238000007428 craniotomy Methods 0.000 description 2
- 238000003487 electrochemical reaction Methods 0.000 description 2
- 210000001061 forehead Anatomy 0.000 description 2
- 239000005338 frosted glass Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 238000002347 injection Methods 0.000 description 2
- 239000007924 injection Substances 0.000 description 2
- QPJSUIGXIBEQAC-UHFFFAOYSA-N n-(2,4-dichloro-5-propan-2-yloxyphenyl)acetamide Chemical compound CC(C)OC1=CC(NC(C)=O)=C(Cl)C=C1Cl QPJSUIGXIBEQAC-UHFFFAOYSA-N 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 238000010791 quenching Methods 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010019196 Head injury Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010022773 Intracranial pressure increased Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 240000007643 Phytolacca americana Species 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000030886 Traumatic Brain injury Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000036770 blood supply Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000008084 cerebral blood perfusion Effects 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000000875 corresponding effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000012466 permeate Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229910052709 silver Inorganic materials 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 230000001360 synchronised effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14553—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases specially adapted for cerebral tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/14551—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters for measuring blood gases
- A61B5/14552—Details of sensors specially adapted therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
- A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
- A61B5/1459—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/02—Details of sensors specially adapted for in-vivo measurements
- A61B2562/0295—Strip shaped analyte sensors for apparatus classified in A61B5/145 or A61B5/157
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B2562/00—Details of sensors; Constructional details of sensor housings or probes; Accessories for sensors
- A61B2562/12—Manufacturing methods specially adapted for producing sensors for in-vivo measurements
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Physics & Mathematics (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Veterinary Medicine (AREA)
- Biomedical Technology (AREA)
- Optics & Photonics (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Neurology (AREA)
- Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
Abstract
Description
技术领域technical field
本发明涉及医疗器械技术领域,特别是涉及一种脑组织血氧饱和度探测装置及其制备方法。The invention relates to the technical field of medical devices, in particular to a brain tissue blood oxygen saturation detection device and a preparation method thereof.
背景技术Background technique
随着现代医疗技术和相关学科的不断发展,医用监测仪器已成为医用电子仪器不可缺少的一大类仪器,在医院中起着越来越重要的作用。监测仪器的使用,不仅减轻了医务人员的劳动,提高医护工作的效率,更重要的是使医生能及时了解病情。With the continuous development of modern medical technology and related disciplines, medical monitoring instruments have become an indispensable category of medical electronic instruments, and play an increasingly important role in hospitals. The use of monitoring instruments not only reduces the labor of medical staff, improves the efficiency of medical care, but more importantly, enables doctors to understand the condition in time.
脑组织供氧是维持生命最基本体征,以及高级生命活动(意识、思维、动作)的物质基础。脑组织缺氧,会导致意识障碍、偏瘫甚至昏迷、死亡。了解脑组织内氧含量具有重要的临床意义。对于颅脑损伤、脑出血、开颅手术的患者,常常伴随脑组织水肿,颅内压增高,脑组织血流灌注不足,以至于对脑组织供氧不足,氧分压或氧饱和度下降,严重威胁患者的生活质量及生命安全,给医疗资源及社会带来沉重的负担。因此,对脑组织含氧情况的监测,是临床实践中亟需解决的问题Oxygen supply to brain tissue is the material basis for maintaining the most basic signs of life and advanced life activities (consciousness, thinking, and action). Hypoxia in brain tissue can lead to disturbance of consciousness, hemiplegia, even coma, and death. Understanding the oxygen content in brain tissue has important clinical significance. For patients with craniocerebral injury, cerebral hemorrhage, and craniotomy, it is often accompanied by brain tissue edema, increased intracranial pressure, and insufficient cerebral blood perfusion, so that the oxygen supply to the brain tissue is insufficient, and oxygen partial pressure or oxygen saturation decreases. Seriously threaten the quality of life and life safety of patients, and bring a heavy burden to medical resources and society. Therefore, monitoring the oxygen content of brain tissue is an urgent problem to be solved in clinical practice.
目前,对脑组织氧含量的监测主要有两种方式:At present, there are two main ways to monitor the oxygen content of brain tissue:
1、有创监测:即外科手术方式,将传感器通过颅骨上的钻孔,或开颅手术形成的骨瓣与颅骨之间的骨缝插入脑组织,并通过皮下隧道走行的方式,从头皮戳孔引出,连接至外部上位机。上位机通过特定的信号处理方法及算法,对脑组织氧分压进行测量。目前成熟的产品主要有德国Raumedic脑氧分压监测系统及美国Camino脑氧分压监测系统。前者(Raumedic)在极细Y型光纤的尖端(单端)涂抹荧光物质,其外涂覆具有生物相容性的透气膜材料,氧分子可扩散至荧光物质处。当外部特定波长激光通过Y型光纤尾端一分支射入,以一定脉冲频率激发荧光物质,荧光物质受激后产生特定波长的荧光。氧分子从脑组织处扩散通过透气膜,接触荧光物质,会引起荧光的淬灭。通过Y型光纤尾端另一分支,可将荧光信号引出。通过外部设备,分析荧光寿命或强度,可以计算尖端氧气含量,从而了解脑氧分压情况。后者(Camino)则在导管尖端制作Clark电极(Au,Ag或Pt等材料),脑组织内氧气透过细胞膜,参与电极间的电化学反应,产生电流。通过外部设备监测电极间的电流大小,可了解电极处脑氧含量。1. Invasive monitoring: that is, the surgical method, the sensor is inserted into the brain tissue through the drill hole on the skull, or the bony seam between the bone flap formed by the craniotomy and the skull, and walks through the subcutaneous tunnel to poke the sensor from the scalp The hole leads out and connects to the external host computer. The upper computer measures the partial pressure of oxygen in the brain tissue through specific signal processing methods and algorithms. At present, the mature products mainly include the German Raumedic cerebral oxygen partial pressure monitoring system and the American Camino cerebral partial pressure oxygen monitoring system. The former (Raumedic) coats the tip (single end) of the ultra-thin Y-shaped optical fiber with a fluorescent substance, which is coated with a biocompatible gas-permeable film material, and oxygen molecules can diffuse to the fluorescent substance. When an external laser with a specific wavelength is injected through a branch at the end of the Y-shaped fiber, the fluorescent substance is excited at a certain pulse frequency, and the fluorescent substance generates fluorescence of a specific wavelength after being excited. Oxygen molecules diffuse from the brain tissue through the gas-permeable membrane and come into contact with fluorescent substances, causing fluorescence quenching. The fluorescent signal can be led out through another branch at the end of the Y-shaped fiber. By analyzing the fluorescence lifetime or intensity with an external device, the oxygen content at the tip can be calculated, so as to understand the partial pressure of oxygen in the brain. The latter (Camino) makes Clark electrodes (materials such as Au, Ag or Pt) at the tip of the catheter. Oxygen in the brain tissue permeates the cell membrane, participates in the electrochemical reaction between the electrodes, and generates current. By monitoring the current between the electrodes with external equipment, the brain oxygen content at the electrodes can be known.
但是,事实上,无论是以激光激发荧光淬灭为基础的光纤传感器,还是Clark电极原理的电化学传感器,均具有较大的局限性。两种传感器监测的脑氧,均为从脑组织细胞中渗透出来的氧气分子。前者氧气分子需要通过透气膜,透气膜的氧气分子透过率严重影响了测量结果的准确性。并且,当监测时间稍长时,荧光物质会产生较大的失活,甚至流失,也严重影响了测量的精度。后者,Clark电极表面一旦有血块或其他物质附着(非常常见的情况),脑组织内氧气将无法参与电极间电化学反应,导致测量不准确甚至失败。此外电化学传感器产生的电流微弱,信号极易在传输过程中受到干扰,影响测量准确性。However, in fact, both the optical fiber sensor based on laser excitation fluorescence quenching and the electrochemical sensor based on the Clark electrode principle have relatively large limitations. The brain oxygen monitored by the two sensors is the oxygen molecule infiltrated from the brain tissue cells. The former oxygen molecules need to pass through the gas-permeable membrane, and the oxygen molecule permeability of the gas-permeable membrane seriously affects the accuracy of the measurement results. Moreover, when the monitoring time is a little longer, the fluorescent substance will be greatly inactivated or even lost, which seriously affects the measurement accuracy. In the latter, once blood clots or other substances are attached to the surface of the Clark electrode (a very common situation), the oxygen in the brain tissue will not be able to participate in the electrochemical reaction between the electrodes, resulting in inaccurate or even failure of measurement. In addition, the current generated by the electrochemical sensor is weak, and the signal is easily disturbed during transmission, which affects the measurement accuracy.
正因如上局限性,且两种技术路线的传感器生产成本高昂,因此,即便如上所说,脑氧监测具有重要意义,这两类传感器在临床中几乎未能使用。Because of the above limitations and the high production cost of the sensors of the two technical routes, even though, as mentioned above, cerebral oxygen monitoring is of great significance, these two types of sensors are hardly used in clinical practice.
2、无创监测:基于NIRS(近红外光谱)原理的无创脑氧监测,近年来开始应用于临床。其基本原理为:将血氧饱和度传感器贴到患者颅脑前额,血氧传感器探头上装有两个不同波段的可见光及近红外二极管,以及可以接受此波段的光电传感器。可见光及红外二极管发出的两个频率的光信号,穿过头皮,颅骨,进入脑组织,被脑组织内各种细胞散射,以类抛物线形式弧形返回,穿过颅骨、头皮等组织,被头皮贴敷的光电传感器接收。血红蛋白及氧合血红蛋白,吸收峰对应发射的两个频率的光信号。根据Lambert-Beer定律,两个频段的光信号吸收强度与血红蛋白及氧合血红蛋白浓度呈正相关。而氧合血红蛋白与血红蛋白的比例,即反应了脑组织内氧饱和度。2. Non-invasive monitoring: Non-invasive cerebral oxygen monitoring based on the principle of NIRS (Near Infrared Spectroscopy) has been applied clinically in recent years. The basic principle is: the blood oxygen saturation sensor is attached to the forehead of the patient's brain, and the blood oxygen sensor probe is equipped with two different bands of visible light and near-infrared diodes, as well as a photoelectric sensor that can accept this band. The light signals of two frequencies emitted by visible light and infrared diodes pass through the scalp and skull, enter the brain tissue, are scattered by various cells in the brain tissue, return in a parabola-like arc, pass through the skull, scalp and other tissues, and are absorbed by the scalp The attached photoelectric sensor receives. For hemoglobin and oxyhemoglobin, the absorption peaks correspond to the emitted light signals of the two frequencies. According to the Lambert-Beer law, the absorption intensity of optical signals in the two frequency bands is positively correlated with the concentration of hemoglobin and oxyhemoglobin. The ratio of oxyhemoglobin to hemoglobin reflects the oxygen saturation in brain tissue.
上述方法监测方便,成本低廉,但局限性也很明显:可见光或近红外光透过皮肤后需要穿过颅骨方可进入脑组织,因此要求二极管及传感器与头皮紧密贴附,且只能应用于颅骨较薄部位。目前此类产品均只能贴敷于额部,无头发覆盖部位。即便如此,光信号进入脑组织及散射至光电传感器,需两次经过颅骨,头皮、颅骨本身血供也会吸收、反射光电信号,带来较大的背景噪声。且经过头皮及颅骨后,信号衰减严重,因此可检测的脑组织表浅,约在脑组织5~10mm深左右。且光信号弥散,无法准确定位,无法对特定脑组织脑氧情况进行监测。The above method is convenient for monitoring and low in cost, but its limitations are also obvious: after visible light or near-infrared light passes through the skin, it needs to pass through the skull before entering the brain tissue. The thinner part of the skull. At present, these products can only be applied to the forehead, and there is no hair covering the area. Even so, the light signal needs to pass through the skull twice to enter the brain tissue and scatter to the photoelectric sensor. The blood supply of the scalp and the skull itself will also absorb and reflect the photoelectric signal, resulting in large background noise. And after passing through the scalp and skull, the signal attenuation is serious, so the detectable brain tissue is superficial, about 5-10mm deep in the brain tissue. Moreover, the optical signal is diffuse, so it cannot be accurately positioned, and the brain oxygen condition of specific brain tissue cannot be monitored.
发明内容Contents of the invention
为克服上述现有技术存在的不足,本发明之目的在于提供一种脑组织血氧饱和度探测装置及其制备方法,以通过在光纤尖端设计简单的反射结构,将光信号引入及引出,实现了特定部位脑氧饱和度的监测需求。In order to overcome the deficiencies in the above-mentioned prior art, the purpose of the present invention is to provide a brain tissue blood oxygen saturation detection device and its preparation method, so that by designing a simple reflection structure at the tip of the optical fiber, the optical signal is introduced and extracted to realize The need for monitoring the oxygen saturation of specific parts of the brain.
为达上述及其它目的,本发明提出一种脑组织血氧饱和度探测装置,包括:测量本体,所述测量本体由若干根并排设置且相互固接的光纤构成,其中一根光纤作为传出光纤,其余光纤作为传入光纤,各传入光纤与传出光纤的尖端相距预设距离,且精密切割或研磨形成预设角度的镜面。In order to achieve the above and other purposes, the present invention proposes a brain tissue blood oxygen saturation detection device, including: a measurement body, the measurement body is composed of several optical fibers arranged side by side and fixed to each other, one of which is used as an outgoing Optical fibers, and the rest of the optical fibers are used as incoming optical fibers. The tips of each incoming optical fiber and outgoing optical fiber are separated by a preset distance, and are precisely cut or ground to form a mirror surface with a preset angle.
优选地,各光纤之间通过采用可植入医疗器械的粘接剂通过粘接方式进行固定。Preferably, the optical fibers are fixed by bonding with an implantable medical device adhesive.
优选地,各光纤的尖端精密切割或研磨,形成预设角度的斜面,并在其斜面处进行镀金或者其他金属,以形成镜面。Preferably, the tip of each optical fiber is precisely cut or ground to form a bevel with a preset angle, and the bevel is plated with gold or other metals to form a mirror surface.
优选地,在金属外部进行涂层或其他方式的修饰,以使其满足脑组织内使用的生物相容性。Preferably, the exterior of the metal is coated or otherwise modified to make it biocompatible for use within brain tissue.
优选地,在各光纤外部使用热缩管、涂层方式,使其表面规则,并能将其内光纤的位置关系保持固定。Preferably, heat-shrinkable tubes and coatings are used outside each optical fiber to make the surface regular and keep the positional relationship of the optical fibers within it fixed.
优选地,传入光纤与传出光纤的尖端之间的距离取决于设计时对检测深度的需要。Preferably, the distance between the tips of the incoming optical fiber and the outgoing optical fiber depends on the need for detection depth during design.
优选地,各光纤的尖端形成的镜面角度为0°-90°,其中不包含0°及90°。Preferably, the mirror angle formed by the tip of each optical fiber is 0°-90°, excluding 0° and 90°.
优选地,在各光纤尖端一定长度,对光纤进行磨平、立方柱、棱柱加工后再形成预设角度的镜面,以破坏光在光纤中的全反射,使光射出或传入。Preferably, at a certain length at the tip of each optical fiber, the optical fiber is ground, cubed, and prism processed, and then a mirror surface with a preset angle is formed to destroy the total reflection of light in the optical fiber, so that the light can be emitted or transmitted.
为达到上述目的,本发明还提供一种脑组织血氧饱和度探测装置的制备方法,包括如下步骤:In order to achieve the above object, the present invention also provides a method for preparing a brain tissue blood oxygen saturation detection device, comprising the following steps:
步骤S1,将若干根光纤的尖端精密切割或研磨,形成预设角度的镜面;Step S1, precision cutting or grinding the tips of several optical fibers to form a mirror surface with a preset angle;
步骤S2,将所述若干根光纤并排设置且相互固接,其中一根光纤作为传出光纤,其余光纤作为传入光纤,各传入光纤与传出光纤的尖端相距预设距离。In step S2, the plurality of optical fibers are arranged side by side and fixed to each other, one of the optical fibers is used as an outgoing optical fiber, and the remaining optical fibers are used as incoming optical fibers, and the tip of each incoming optical fiber is separated from the tip of the outgoing optical fiber by a preset distance.
优选地,于步骤S1中,将各光纤尖端一定长度,对光纤进行磨平、立方柱、棱柱加工后再形成预设角度的镜面,以破坏光在光纤中的全反射,使光射出或传入。Preferably, in step S1, the tip of each optical fiber is given a certain length, and the optical fiber is ground, cubed and prism processed to form a mirror surface with a preset angle, so as to destroy the total reflection of light in the optical fiber, so that the light is emitted or transmitted enter.
与现有技术相比,本发明提供一种脑组织血氧饱和度探测装置及其制备方法,以通过在光纤尖端设计简单的反射结构,将光信号引入及引出,实现了在体内(不仅可以是脑组织,还可以是血管内、肝脏、肾脏等)进行有创组织氧饱和度监测的目的。Compared with the prior art, the present invention provides a brain tissue blood oxygen saturation detection device and its preparation method, so that by designing a simple reflection structure at the tip of the optical fiber, the optical signal is introduced and extracted, and realized in the body (not only can It is brain tissue, and it can also be intravascular, liver, kidney, etc.) for the purpose of invasive tissue oxygen saturation monitoring.
附图说明Description of drawings
图1为本发明一种脑组织血氧饱和度探测装置的结构示意图;Fig. 1 is a schematic structural view of a brain tissue blood oxygen saturation detection device of the present invention;
图2为本发明之脑组织血氧饱和度探测装置的原理示意图;2 is a schematic diagram of the principle of the brain tissue blood oxygen saturation detection device of the present invention;
图3为本发明具体实施例中避免光的全反射示意图;Fig. 3 is a schematic diagram of avoiding total reflection of light in a specific embodiment of the present invention;
图4为本发明一种脑组织血氧饱和度探测装置的制备方法的步骤流程图。FIG. 4 is a flow chart of steps of a method for manufacturing a device for detecting blood oxygen saturation in brain tissue according to the present invention.
具体实施方式Detailed ways
以下通过特定的具体实例并结合附图说明本发明的实施方式,本领域技术人员可由本说明书所揭示的内容轻易地了解本发明的其它优点与功效。本发明亦可通过其它不同的具体实例加以施行或应用,本说明书中的各项细节亦可基于不同观点与应用,在不背离本发明的精神下进行各种修饰与变更。The implementation of the present invention is described below through specific examples and in conjunction with the accompanying drawings, and those skilled in the art can easily understand other advantages and effects of the present invention from the content disclosed in this specification. The present invention can also be implemented or applied through other different specific examples, and various modifications and changes can be made to the details in this specification based on different viewpoints and applications without departing from the spirit of the present invention.
图1为本发明一种脑组织血氧饱和度探测装置的结构示意图。如图1所示,本发明一种脑组织血氧饱和度探测装置,包括:测量本体,所述测量本体由若干根并排设置,其中一根光纤作为传出光纤,其余光纤作为传入光纤,各传入光纤与传出光纤的尖端相距一定距离,各光纤之间相互固接,例如通过粘接等方式(例如采用可植入医疗器械的粘接剂)进行固定,必要时,可在各光纤外部使用热缩管(C)、涂层等方式,使其表面规则,并能将其内光纤的位置关系保持固定;各光纤的尖端精密切割或研磨,形成一定角度的斜面,并在其斜面处进行镀金或者其他金属,以形成镜面。优选地,必要时可在金属外部进行涂层或其他方式的修饰,以使其满足脑组织内使用的生物相容性。优选地,为满足体内使用,所使用的光纤应满足可消毒灭菌。在本发明中,具体光纤的数量及斜面角度可根据实际需求调整。FIG. 1 is a schematic structural diagram of a brain tissue blood oxygen saturation detection device according to the present invention. As shown in Figure 1, a brain tissue blood oxygen saturation detection device of the present invention includes: a measuring body, the measuring body is arranged side by side, one of the optical fibers is used as an outgoing optical fiber, and the remaining optical fibers are used as incoming optical fibers. There is a certain distance between the tips of the incoming optical fibers and the outgoing optical fibers, and the optical fibers are fixed to each other, for example, by bonding (such as using an implantable adhesive for medical devices) to fix them. If necessary, they can be fixed at each Heat-shrinkable tube (C) and coating are used outside the optical fiber to make the surface regular and keep the positional relationship of the optical fiber inside; the tip of each optical fiber is precisely cut or ground to form a bevel at a certain angle, Gold plating or other metals are carried out on the slope to form a mirror surface. Preferably, the exterior of the metal can be coated or modified in other ways if necessary, so as to meet the biocompatibility for use in brain tissue. Preferably, for in vivo use, the optical fiber used should be sterilizable. In the present invention, the number of specific optical fibers and the angle of the slope can be adjusted according to actual needs.
在本发明具体实施例中,以两根光纤(A,B)为例,其中A为传入光纤,B为传出光纤,传入光纤A与传出光纤B两个带镜面的尖端距离,取决于设计时对检测深度(检测范围)的需要,如果需要检测更大范围的脑组织,可以根据需要将两个带镜面的尖端之间的距离加大,反之亦然,具体的距离参数与检测范围的关系,可根据抛物线拟合公式进行计算,这在现有技术的文献中已有揭露,在此不予赘述。In a specific embodiment of the present invention, two optical fibers (A, B) are taken as an example, wherein A is an incoming optical fiber, B is an outgoing optical fiber, and the distance between the tips of the incoming optical fiber A and the outgoing optical fiber B with two mirror surfaces is, Depending on the need for detection depth (detection range) during design, if a larger range of brain tissue needs to be detected, the distance between the two mirrored tips can be increased as required, and vice versa. The specific distance parameters are related to The relationship between the detection range can be calculated according to the parabola fitting formula, which has been disclosed in the literature of the prior art, and will not be repeated here.
对于传入光纤A与传出光纤B所形成的两个镜面的角度,可设置为0°-90°之间(这里不含0°及90°,因为当0°时,反射镜面几乎与入射光平行,漫反射光线进入光纤后无法反射;90°,则光纤无法加工)。具体的角度值,需要根据光纤加工以及实际应用场景来设计。一般来说在45°时,光线进入光线,经镜面反射正好可以沿光线长轴传导,理论上衰减最少,可获得最大检测光强,检测更为灵敏,因此在本发明具体实施例中,传入光纤A与传出光纤B的斜面(M,N)角度为45°,并在斜面处(M,N)进行镀金或者其他金属,形成镜面。For the angle of the two mirrors formed by the incoming fiber A and the outgoing fiber B, it can be set between 0°-90° (0° and 90° are not included here, because when 0°, the reflecting mirror is almost the same as the incident If the light is parallel, the diffuse reflection light cannot be reflected after entering the fiber; if it is 90°, the fiber cannot be processed). The specific angle value needs to be designed according to fiber processing and actual application scenarios. Generally speaking, when the light enters the light at 45°, it can be transmitted along the long axis of the light after being reflected by the mirror surface. Theoretically, the attenuation is the least, the maximum detection light intensity can be obtained, and the detection is more sensitive. Therefore, in the specific embodiment of the present invention, transmission The slope (M, N) angle between the input fiber A and the output fiber B is 45°, and the slope (M, N) is plated with gold or other metals to form a mirror.
如图2所示,在使用时,从传入光纤A交替引入不同频率的光信号,此信号经过传入光纤A尖端的M镜面反射,进入脑组织,散射光通过B光纤的N镜面反射,将光信号由B光纤引出,在体外设备进行同步测量。当交替引入血红蛋白和氧合血红蛋白特异吸收峰波长的光信号时,可以交替测量到相应的吸收强度,从而了解脑组织氧饱和度情况。As shown in Figure 2, when in use, optical signals of different frequencies are alternately introduced from the incoming fiber A, the signal is reflected by the M mirror at the tip of the incoming fiber A, and enters the brain tissue, and the scattered light is reflected by the N mirror of the B fiber, The optical signal is led out from the B optical fiber, and the in vitro device is used for synchronous measurement. When the light signals of the specific absorption peak wavelengths of hemoglobin and oxyhemoglobin are alternately introduced, the corresponding absorption intensity can be measured alternately, so as to understand the oxygen saturation of the brain tissue.
实际上,脑组织的氧饱和度变化在ms级别时间中是相对稳定的,因此,当传入光纤A引入的不同波长的光信号,切换频率较快时(ms级别),可近似认为所测得的血红蛋白吸收峰强度和氧合血红蛋白吸收峰强度为同一时刻。In fact, the change of oxygen saturation of brain tissue is relatively stable in the time of ms level. Therefore, when the optical signals of different wavelengths introduced by the incoming fiber A are switched at a faster frequency (ms level), it can be approximately considered that the measured The obtained hemoglobin absorption peak intensity and oxyhemoglobin absorption peak intensity are at the same time.
优选地,如有严格要求,需要“同时”测量两种频率的光信号吸收强度,可增加一根光纤作为传入光纤,仍按如上要求并排排列,其尖端按一定距离与B光纤间隔。Preferably, if there are strict requirements, and it is necessary to "simultaneously" measure the absorption intensity of optical signals of two frequencies, an optical fiber can be added as an incoming optical fiber, which is still arranged side by side according to the above requirements, and its tip is spaced from the B optical fiber at a certain distance.
优选地,为了传入光纤的光信号能够顺利射出光纤,以及脑组织反射光信号能够顺利进入传出光纤,需要避免光的全反射情况。因此,需要将光纤尖端一定长度,通过研磨等方式,将原有圆柱形加工成棱柱,或四侧面的立方柱状。一般地说,光纤的作用是让光在玻璃材质内传输而不透过材料,是指光纤在传输中,因为全反射原理,无法穿过光纤与周围空气或其他物质的圆形界面。因此,在需要各光纤射出或传入的部分(即光纤尖端镜面处),可以采取包括但不限于如下两种方式:1.对光纤表面进行氢氟酸(HF)腐蚀,使其“雾化”,光滑的表面变粗糙,类似于“毛玻璃”一样的效果,破坏光纤与相邻介质的圆形界面,达到射出或传入的目的;2.将圆形界面进行研磨,变成平面或多边形,亦可使光线射出或传入,如图3所示,只需破坏d处光纤界面的圆形,不管是磨平,雾化,还是形成其他形状(棱柱),均可破坏光在光纤中的全反射,使光射出或传入。Preferably, total reflection of light needs to be avoided in order that the optical signal transmitted into the optical fiber can exit the optical fiber smoothly, and the optical signal reflected by the brain tissue can enter the outgoing optical fiber smoothly. Therefore, it is necessary to cut the fiber tip to a certain length, and process the original cylindrical shape into a prism or a cubic column with four sides by grinding or other means. Generally speaking, the function of an optical fiber is to allow light to transmit in the glass material without passing through the material, which means that the optical fiber cannot pass through the circular interface between the optical fiber and the surrounding air or other substances due to the principle of total reflection during transmission. Therefore, in the part where each fiber needs to be emitted or passed in (that is, at the mirror surface of the fiber tip), two methods including but not limited to the following can be adopted: 1. Corrosion with hydrofluoric acid (HF) on the surface of the fiber to make it "atomized" ", the smooth surface becomes rough, similar to the effect of "frosted glass", destroying the circular interface between the optical fiber and the adjacent medium to achieve the purpose of injection or transmission; 2. Grinding the circular interface to become a plane or polygon , can also make the light exit or pass in, as shown in Figure 3, only need to destroy the circular shape of the fiber interface at d, whether it is ground, atomized, or formed into other shapes (prisms), the light in the fiber can be destroyed The total reflection of the light exits or enters.
图4为本发明一种脑组织血氧饱和度探测装置的制备方法的步骤流程图。如图4所示,本发明一种脑组织血氧饱和度探测装置的制备方法,包括如下步骤:FIG. 4 is a flow chart of steps of a method for manufacturing a device for detecting blood oxygen saturation in brain tissue according to the present invention. As shown in Figure 4, a method for preparing a brain tissue blood oxygen saturation detection device of the present invention comprises the following steps:
步骤S1,将若干根光纤的尖端精密切割或研磨,形成一定角度的斜面,并于斜面处进行镀金或其他金属,形成镜面。In step S1, the tips of several optical fibers are precisely cut or ground to form a slope with a certain angle, and gold or other metals are plated on the slope to form a mirror surface.
在本发明具体实施例中,各光纤尖端斜面的角度在0°-90°之间(这里不含0°及90°,因为当0°时,反射镜面几乎与入射光平行,漫反射光线进入光纤后无法反射;90°,则光纤无法加工)。具体的角度值,需要根据光纤加工以及实际应用场景来设计。一般来说在45°时,光线进入光线,经镜面反射正好可以沿光线长轴传导,理论上衰减最少,可获得最大检测光强,检测更为灵敏,因此在本发明具体实施例中,以两根光纤A,B为例,将其尖端精密切割或研磨,形成的尖端斜面(M,N)角度为45°,并在斜面处(M,N)进行镀金或者其他金属,形成镜面。必要时还可在金属外部进行涂层或其他方式的修饰,以使其满足脑组织内使用的生物相容性。In a specific embodiment of the present invention, the angle of each fiber tip bevel is between 0°-90° (excluding 0° and 90° here, because when 0°, the mirror surface is almost parallel to the incident light, and the diffuse reflection light enters It cannot be reflected behind the fiber; at 90°, the fiber cannot be processed). The specific angle value needs to be designed according to fiber processing and actual application scenarios. Generally speaking, when the light enters the light at 45°, it can be transmitted along the long axis of the light through mirror reflection. Theoretically, the attenuation is the least, the maximum detection light intensity can be obtained, and the detection is more sensitive. Therefore, in the specific embodiment of the present invention, Take two optical fibers A and B as an example. The tips are precisely cut or ground to form a tip bevel (M, N) with an angle of 45°, and the bevel (M, N) is plated with gold or other metals to form a mirror. If necessary, the exterior of the metal can be coated or modified in other ways to meet the biocompatibility for use in brain tissue.
步骤S2,将所述若干根光纤并排设置并相互固定,其中一根为作为传出光纤,其他作为传入光纤,各传入光纤与传出尖端相距一定距离。在本发明具体实施例中,各光纤通过粘接等方式进行固定。必要时,可在光纤外部使用热缩管、涂层等方式,使其表面规则,并能将其内光纤的位置关系保持固定。In step S2, the plurality of optical fibers are arranged side by side and fixed to each other, one of which is used as an outgoing optical fiber, and the others are used as incoming optical fibers, and each incoming optical fiber is at a certain distance from the outgoing tip. In a specific embodiment of the present invention, each optical fiber is fixed by means of bonding or the like. If necessary, heat-shrinkable tubes, coatings, etc. can be used on the outside of the optical fiber to make the surface regular and keep the positional relationship of the optical fiber inside it fixed.
在本发明具体实施例中,仍以上述两根光纤(A,B)为例,A,B光纤并排设置,尖端相距一定距离,通过粘接等方式进行固定,其中A为传入光纤,B为传出光纤,传入光纤A与传出光纤B两个带镜面的尖端距离,取决于设计时对检测深度(检测范围)的需要,如果需要检测更大范围的脑组织,可以根据需要将两个带镜面的尖端之间的距离加大,反之亦然,具体的距离参数与检测范围的关系,可根据抛物线拟合公式进行计算,这在现有技术的文献中已有揭露,在此不予赘述。In the specific embodiment of the present invention, still taking the above two optical fibers (A, B) as an example, the A and B optical fibers are arranged side by side, with the tips separated by a certain distance, and are fixed by bonding or other methods, wherein A is the incoming optical fiber, and B is the incoming optical fiber. As the outgoing fiber, the distance between the two mirrored tips of the incoming fiber A and the outgoing fiber B depends on the need for detection depth (detection range) during design. If a larger range of brain tissue needs to be detected, the The distance between the tips of the two mirrors increases, and vice versa. The relationship between the specific distance parameter and the detection range can be calculated according to the parabola fitting formula, which has been disclosed in the literature of the prior art. Here I won't go into details.
优选地,为了传入光纤的光信号能够顺利射出光纤,以及脑组织反射光信号能够顺利进入传出光纤,需要避免光的全反射情况。因此,于步骤S1中,还需要将光纤尖端一定长度,通过研磨等方式,将原有圆柱形加工成棱柱,或四侧面的立方柱状。一般地说,光纤的作用是让光在玻璃材质内传输而不透过材料,是指光纤在传输中,因为全反射原理,无法穿过光纤与周围空气或其他物质的圆形界面。因此,在需要各光纤射出或传入的部分(即光纤尖端镜面处),可以采取包括但不限于如下两种方式:1.对光纤表面进行氢氟酸(HF)腐蚀,使其“雾化”,光滑的表面变粗糙,类似于“毛玻璃”一样的效果,破坏光纤与相邻介质的圆形界面,达到射出或传入的目的;2.将圆形界面进行研磨,变成平面或多边形,亦可使光线射出或传入。Preferably, total reflection of light needs to be avoided in order that the optical signal transmitted into the optical fiber can exit the optical fiber smoothly, and the optical signal reflected by the brain tissue can enter the outgoing optical fiber smoothly. Therefore, in step S1 , it is also necessary to grind the tip of the optical fiber to a certain length, and process the original cylindrical shape into a prism or a cubic column with four sides by grinding or other means. Generally speaking, the function of an optical fiber is to allow light to transmit in the glass material without passing through the material, which means that the optical fiber cannot pass through the circular interface between the optical fiber and the surrounding air or other substances due to the principle of total reflection during transmission. Therefore, in the part where each fiber needs to be emitted or passed in (that is, at the mirror surface of the fiber tip), two methods including but not limited to the following can be adopted: 1. Corrosion with hydrofluoric acid (HF) on the surface of the fiber to make it "atomized" ", the smooth surface becomes rough, similar to the effect of "frosted glass", destroying the circular interface between the optical fiber and the adjacent medium to achieve the purpose of injection or transmission; 2. Grinding the circular interface to become a plane or polygon , also allows light to exit or enter.
上述实施例仅例示性说明本发明的原理及其功效,而非用于限制本发明。任何本领域技术人员均可在不违背本发明的精神及范畴下,对上述实施例进行修饰与改变。因此,本发明的权利保护范围,应如权利要求书所列。The above-mentioned embodiments only illustrate the principles and effects of the present invention, but are not intended to limit the present invention. Any person skilled in the art can modify and change the above-mentioned embodiments without departing from the spirit and scope of the present invention. Therefore, the protection scope of the present invention should be listed in the claims.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011114382.2A CN112168181B (en) | 2020-10-16 | 2020-10-16 | Brain tissue blood oxygen saturation detection device and preparation method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011114382.2A CN112168181B (en) | 2020-10-16 | 2020-10-16 | Brain tissue blood oxygen saturation detection device and preparation method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112168181A CN112168181A (en) | 2021-01-05 |
CN112168181B true CN112168181B (en) | 2023-07-11 |
Family
ID=73950729
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011114382.2A Active CN112168181B (en) | 2020-10-16 | 2020-10-16 | Brain tissue blood oxygen saturation detection device and preparation method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112168181B (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331570A (en) * | 1998-10-19 | 2002-01-16 | 里奥格兰德医学技术有限公司 | Method for non-invasive blood analyte measurement with improved optical interface |
CN104677290A (en) * | 2015-03-05 | 2015-06-03 | 哈尔滨工业大学 | Method for manufacturing double-core fiber grating micro-scale measurement probe based on self-assembly principle |
CN106596474A (en) * | 2016-12-05 | 2017-04-26 | 重庆三峡学院 | Three-channel SPR (surface plasma resonance) sensor based on seven-core optical fiber |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1547515A1 (en) * | 2003-12-22 | 2005-06-29 | Barts and The London National Health Service Trust | Optical fibre catheter pulse oximeter |
EP2157462A1 (en) * | 2008-08-22 | 2010-02-24 | Pulsion Medical Systems AG | Fiber-optic probe |
-
2020
- 2020-10-16 CN CN202011114382.2A patent/CN112168181B/en active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1331570A (en) * | 1998-10-19 | 2002-01-16 | 里奥格兰德医学技术有限公司 | Method for non-invasive blood analyte measurement with improved optical interface |
CN104677290A (en) * | 2015-03-05 | 2015-06-03 | 哈尔滨工业大学 | Method for manufacturing double-core fiber grating micro-scale measurement probe based on self-assembly principle |
CN106596474A (en) * | 2016-12-05 | 2017-04-26 | 重庆三峡学院 | Three-channel SPR (surface plasma resonance) sensor based on seven-core optical fiber |
Also Published As
Publication number | Publication date |
---|---|
CN112168181A (en) | 2021-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7277740B2 (en) | Analysis system for reagent-free determination of the concentration of an analyte in living tissue | |
Mignani et al. | Biomedical sensors using optical fibres | |
JP3625475B2 (en) | Non-intrusive system for monitoring hematocrit values | |
US6041247A (en) | Non-invasive optical measuring sensor and measuring method | |
US8352005B2 (en) | Noninvasive blood analysis by optical probing of the veins under the tongue | |
US6681128B2 (en) | System for noninvasive hematocrit monitoring | |
Nawaz et al. | Non-invasive continuous blood glucose measurement techniques | |
US9086533B1 (en) | Method and system for coupling light through challenging media | |
US20090088615A1 (en) | Indwelling Fiber Optic Probe for Blood Glucose Measurements | |
Petrova et al. | Noninvasive monitoring of cerebral blood oxygenation in ovine superior sagittal sinus with novel multi-wavelength optoacoustic system | |
JPH06261890A (en) | Sensor device | |
Petrov et al. | Optoacoustic monitoring of cerebral venous blood oxygenation through extracerebral blood | |
US8249697B2 (en) | Cardiac output monitor with compensation for tissue perfusion | |
Barker et al. | Continuous Measurement of Intraarterial pHa, Paco2, and Pao2, in the Operating Room | |
WO2009061769A1 (en) | Measurement of hematocrit and cardiac output from optical transmission and reflection changes | |
CN109924987A (en) | Scaling method, system and the readable storage medium storing program for executing of reflectance oximetry | |
CN110537926B (en) | Needle, device and method for detecting hemoglobin concentration and blood oxygen saturation | |
AU2002322640A1 (en) | Continuous optoacoustic monitoring of hemoglobin concentration and hematocrit | |
Takatani et al. | Optical oximetry sensors for whole blood and tissue | |
CN112168181B (en) | Brain tissue blood oxygen saturation detection device and preparation method thereof | |
JP2008289807A (en) | Sensing apparatus for biological surface tissue | |
CN206526025U (en) | A kind of detecting head for brain scans | |
US7508999B2 (en) | Fiber optic sensor device for measuring chromophoric compounds in biological fluid | |
Baldini et al. | Optical-fiber medical sensors | |
JP3876322B2 (en) | Non-invasive brain activity measurement method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |